Detalhe da pesquisa
1.
Erratum to: Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults ≥50 Years of Age.
J Infect Dis;
223(2): 353, 2021 02 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33215671
2.
Dihydroxyphenylglycol as a Biomarker of Norepinephrine Transporter Inhibition by Atomoxetine: Human Model to Assess Central and Peripheral Effects of Dosing.
J Clin Psychopharmacol;
36(6): 675-683, 2016 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27755221
3.
Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age.
J Infect Dis;
208(12): 1953-61, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23904292
4.
A phase 1/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein e subunit vaccine candidate in young and older adults.
J Infect Dis;
206(8): 1280-90, 2012 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22872734
5.
ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling.
Vaccine;
38 Suppl 2: B65-B75, 2020 12 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31677947
6.
Attributes influencing parental decision-making to receive the Tdap vaccine to reduce the risk of pertussis transmission to their newborn - outcome of a cross-sectional conjoint experiment in Spain and Italy.
Hum Vaccin Immunother;
15(5): 1080-1091, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30735474
7.
Benefit Versus Risk Assessment of Rotavirus Vaccination in France: A Simulation and Modeling Analysis.
BioDrugs;
32(2): 139-152, 2018 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29589230
8.
Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention.
Expert Rev Vaccines;
17(7): 619-634, 2018 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30028651
9.
Post-Marketing Benefit-Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis.
Drug Saf;
39(3): 219-30, 2016 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26748506
10.
Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: a phase II, randomized, controlled study.
Vaccine;
32(15): 1745-53, 2014 Mar 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24508036
11.
Sampling of herpes zoster skin lesion types and the impact on viral DNA detection.
J Virol Methods;
188(1-2): 145-7, 2013 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23275023
12.
Improved CD4⺠T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trial.
Vaccine;
31(17): 2196-206, 2013 Apr 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22643213
13.
Applying concepts of generalizability theory on data from experimental pain studies to investigate reliability.
Basic Clin Pharmacol Toxicol;
105(2): 105-12, 2009 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19389040
14.
A Bayesian approach for dose-escalation in a Phase I clinical trial incorporating pharmacodynamic endpoints.
J Biopharm Stat;
17(6): 1117-29, 2007.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18027220